Ribosome engineering and fermentation optimization leads to overproduction of tiancimycin A, a new enediyne natural product from Streptomyces sp. CB03234

J Ind Microbiol Biotechnol. 2018 Mar;45(3):141-151. doi: 10.1007/s10295-018-2014-8. Epub 2018 Feb 2.

Abstract

Tiancimycin (TNM) A, a recently discovered enediyne natural product from Streptomyces sp. CB03234, showed rapid and complete killing of cancer cells and could be used as a payload in antibody drug conjugates. The low yield of TNM A in the wild-type strain promoted us to use ribosome engineering and fermentation optimization for its yield improvement. The Streptomyces sp. CB03234-R-16 mutant strain with a L422P mutation in RpoB, the RNA polymerase β-subunit, was obtained from the rifamycin-resistant screening. After fermentation optimization, the titers of TNM A in Streptomyces sp. CB03234-R-16 reached to 22.5 ± 3.1 mg L-1 in shaking flasks, and 13 ± 1 mg L-1 in 15 L fermentors, which were at least 40-fold higher than that in the wild-type strain (~ 0.3 mg L-1). Quantitative real-time RT-PCR revealed markedly enhanced expression of key genes encoding TNM A biosynthetic enzymes and regulators in Streptomyces sp. CB03234-R-16. Our study should greatly facilitate the future efforts to develop TNM A into a clinical anticancer drug.

Keywords: Enediyne natural product; In situ resin adsorption; Ribosome engineering; RpoB; Tiancimycin A.

MeSH terms

  • Adsorption
  • Antineoplastic Agents / metabolism
  • Biological Products / metabolism*
  • Chemistry, Pharmaceutical / methods
  • DNA-Directed RNA Polymerases / metabolism
  • Drug Design
  • Enediynes / metabolism*
  • Fermentation*
  • Industrial Microbiology / methods
  • Mutation
  • Real-Time Polymerase Chain Reaction
  • Ribosomes / chemistry*
  • Rifamycins / chemistry*
  • Streptomyces / genetics*

Substances

  • Antineoplastic Agents
  • Biological Products
  • Enediynes
  • Rifamycins
  • tiancimycin A
  • rifamycin SV
  • DNA-Directed RNA Polymerases
  • RNA polymerase beta subunit